Search bioRxiv⌕ Search

Biology subjects

Gan, Z.

Publications and source records attributed to Gan, Z..

13 recordsLinked to original sources

CatESO: Differentiable Enzyme Sequence Optimization Guided by Substrate-Aware kcat Prediction

Enzymes drive biological chemistry and offer greener routes to chemicals, materials and medicines, yet their broader use as biocatalysts is often limited by insufficient catalytic turnover. Improving turnover is hard: measured rate constants are scarce and protein sequence space is vast. Deep-learning models now predict the turnover number, kcat, with growing accuracy, but they are typically applied after sequence generation to score or filter candidates, which separates the kinetic objective from the design itself. To bridge the gap between sequence generation and kinetic evaluation, we introduce CatESO, a differentiable sequence optimizer that enables direct, gradient-guided design of substrate-specific catalytic turnover. By backpropagating through a cross-modal kcat predictor under continuous sequence relaxation, CatESO co-optimizes predicted catalytic activity, evolutionary plausibility and structural integrity in one end-to-end framework, using ESM-2 and ESMFold to keep designs evolutionarily plausible and foldable. Across seven stringent out-of-distribution enzymes spanning EC classes 1-7, CatESO raised model-predicted kcat for the vast majority of designs, with a median predicted fold change of 1.52 while every variant retained a pLDDT above 70. Against RFdiffusion3-LigandMPNN pipeline and ZymCtrl, CatESO struck a better balance between predicted activity and structural confidence. By making substrate-conditioned kinetic objectives differentiable, CatESO carries differentiable protein design beyond structure- and binding-centred goals to enzyme catalytic function, giving a general route to function-oriented enzyme engineering.

biochemistry↗

Macrophage Iron Metabolism in Allografts and Tumors

Macrophages are present at high frequencies in transplanted organs and solid tumors. These infiltrating macrophages are highly tuned by tissue niche signals. However, the underlying mechanisms that orchestrate the activation of distinct macrophage populations remain unclear. Here, using heart transplantation and tumor implantation models, we found that macrophages in cardiac allografts exhibited higher intracellular iron (Fe2+) level and higher expression of the iron transporter SLC11A1 than those in the solid tumors. In mice, the myeloid-specific deletion of Slc11a1 alleviated the proinflammatory state of macrophages and cardiac allografts rejection. Together, our findings identify SLC11A1 as a new player in immune response regulation, implicating SLC11A1 as a therapeutic target for both allograft and tumor rejection. This preprint reports initial findings; additional experiments are ongoing and will be included in a future full manuscript.

immunology↗

DeepPGDB: A Novel Paradigm for AI-Guided Interactive Plant Genomic Database

DeepPGDB (https://www.deeppgdb.chat) is the first AI-driven plant genomics database designed to lower technical barriers in multi-omics research by enabling natural language-based data access and analysis. Integrating over 50 high-quality plant genomes, DeepPGDB combines fine-tuned large language models (LLMs) with prompt engineering to interpret user queries, generate standardized bioinformatics commands, and retrieve or visualize genomic data. Key functionalities include sequence retrieval, BLAST alignment, gene localization, expression profiling, and population genetics analysis, all presented via an intuitive conversational interface. A summarization module further enhances biological reasoning, inferring insights such as haplotype differentiation or protein properties. Benchmarking revealed that Deepseek-r1:14b optimized for short pre-prompts delivers high accuracy and speed. By bridging computational and biological expertise, DeepPGDB democratizes genomic research, fostering interdisciplinary collaboration and accelerating discoveries in agriculture and biotechnology.

bioinformatics↗

The metabolic enzyme GYS1 condenses with NONO/p54nrb in the nucleus to spatiotemporally regulate glycogenesis and myogenic differentiation

Accumulating evidence indicates that metabolic enzymes can directly couple metabolic signals to transcriptional adaptation and cell differentiation. Glycogen synthase 1 (GYS1), the key metabolic enzyme for glycogenesis, is a nucleocytoplasmic shuttling protein compartmentalized in the cytosol and nucleus. However, the spatiotemporal regulation and biological function of nuclear GYS1 (nGYS1) microcompartments remain unclear. Here, we show that GYS1 dynamically reorganizes into nuclear condensates under conditions of glycogen depletion or transcription inhibition. nGYS1 complexes with the transcription factor NONO/p54nrb and undergoes liquid-liquid phase separation to form biomolecular condensates, leading to its nuclear retention and inhibition of glycogen biosynthesis. Compared to their wild-type littermates, Nono-deficient mice exhibit exercise intolerance, higher muscle glycogen content, and smaller myofibers. Additionally, Gys1 or Nono deficiency prevents C2C12 differentiation and cardiotoxin-induced muscle regeneration in mice. Mechanistically, nGYS1 and NONO co-condense with the myogenic transcription factor MyoD and preinitiation complex (PIC) proteins to form transcriptional condensates, driving myogenic gene expression during myoblast differentiation. These results reveal the spatiotemporal regulation and subcellular function of nuclear GYS1 condensates in glycogenesis and myogenesis, providing mechanistic insights into glycogenoses and muscular dystrophy.

cell biology↗

SCAD Delivery Platform: A Novel Approach for Efficient CNS and Extrahepatic Oligonucleotide Therapeutics

Oligonucleotide therapeutics, including antisense oligonucleotides (ASOs) and duplex RNAs like siRNA, saRNA, and miRNA, hold immense potential for treating genetic and acquired diseases by modulating gene expression in a target-specific manner. However, effective delivery to extrahepatic tissues, particularly the central nervous system (CNS), remains a significant challenge. While GalNAc conjugation has enabled liver-specific delivery, leading to several approved siRNA drugs for hepatic targets, CNS delivery lags. ASOs, on the other hand, can self-deliver to the CNS when administered locally, as seen with nusinersen and tofersen. To address this disparity, weve developed the Smart Chemistry Aided Delivery (SCAD) platform which enables duplex RNA delivery by conjugating it to an accessory oligonucleotide (ACO), which acts as an aptamer to mediate protein binding and facilitate cellular uptake. Through extensive screening, we identified an optimal SCAD architecture that demonstrates enhanced cell-free protein binding and in vitro activity. In rodent models, local administration of SCAD-siRNA conjugates resulted in broad biodistribution throughout the CNS and sustained mRNA knockdown for over five months, with a favorable safety profile. The SCAD platform also exhibited efficient delivery to other tissues, including the eye, the lung and the joint. These features support its potential for broader clinical applications, as evidenced by an ongoing trial targeting amyotrophic lateral sclerosis (ALS) associated with mutations in the SOD1 gene. The modular design of SCAD allows it to easily adapt to any duplex RNA, making it a powerful tool for advancing oligonucleotide therapeutics.

neuroscience↗

RAG-17: A Novel siRNA Conjugate Demonstrating Efficacy in Late-Stage Treatment of SOD1G93A ALS mice

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by rapid progression and high mortality. With genetic mutations, particularly in the SOD1 gene, playing a significant role in ALS pathogenesis, targeted therapies have become a primary focus. This study introduces RD-12500 (RAG-17), a novel siRNA-ACO (Accessory Oligonucleotide) conjugate designed to address the challenges of delivering duplex RNAs to the central nervous system (CNS). RD-12500 exhibits remarkable in vitro stability and target specificity with minimal immunostimulation. In vivo studies demonstrate its extensive CNS biodistribution, sustained accumulation post-intrathecal administration, and a robust dose-exposure-activity correlation. Notably, RD-12500 significantly reduces cerebrospinal fluid (CSF) SOD1 protein levels, indicating potent SOD1 mRNA and protein knockdown in cynomolgus monkeys. Most notably, our study breaks new ground by demonstrating the effectiveness of RD-12500 in late-stage treatment scenarios. In SOD1G93A ALS mice, post-onset administration of RD-12500 significantly delayed disease progression, improved motor function, and extended survival, marking a significant advancement over other treatments which are typically initiated pre-symptomatically in the same model mice. These findings suggest RD-12500s potential to provide therapeutic benefits not only to pre-symptomatic but also to post-symptomatic and late-stage SOD1-ALS patients.

pharmacology and toxicology↗

Nifuroxazide enhances radiotherapy efficacy against hepatocellular carcinoma by upregulating PD-L1 degradation via the ubiquitin-proteasome pathway

Radiation therapy is a primary treatment for hepatocellular carcinoma (HCC), but its effectiveness can be diminished by various factors. The over-expression of PD-L1 has been identified as a critical reason for radiotherapy resistance. Previous studies have demonstrated that nifuroxazide exerts antitumor activity by damaging the Stat3 pathway, but its efficacy against PD-L1 has remained unclear. In this study, we investigated whether nifuroxazide could enhance the efficacy of radiotherapy in HCC by reducing PD-L1 expression. Our results showed that nifuroxazide significantly increased the sensitivity of tumor cells to radiation therapy by inhibiting cell proliferation and migration while increasing apoptosis in vitro. Additionally, nifuroxazide attenuated the up-regulation of PD-L1 expression induced by irradiation, which may be associated with increased degradation of PD-L1 through the ubiquitination-proteasome pathway. Furthermore, nifuroxazide greatly enhanced the efficacy of radiation therapy in H22-bearing mice by inhibiting tumor growth, improving survival, boosting the activation of T lymphocytes, and decelerating the ratios of Treg cells in spleens. Importantly, nifuroxazide limited the increased expression of PD-L1 in tumor tissues induced by radiation therapy. This study confirms, for the first time, that nifuroxazide can augment PD-L1 degradation to improve the efficacy of radiation therapy in HCC-bearing mice.

immunology↗

Local administration of a novel siRNA modality into the CNS extends survival and improves motor function in the SOD1G93A mouse model for ALS

Antisense oligonucleotides (ASOs) were the first modality to pioneer targeted gene knockdown in the treatment of ALS caused by mutant superoxide dismutase 1 (SOD1). RNA interference (RNAi) is another mechanism of gene silencing with historically superior potency in which short interfering RNAs (siRNAs) guide the RNA-induced silencing complex (RISC) to cleave complementary transcripts. However, delivery to extrahepatic tissues like the central nerve system (CNS) has been a bottleneck in the clinical development of RNAi. Herein, we identify potent siRNA duplexes for the knockdown of human SOD1 (hSOD1) in which medicinal chemistry and conjugation to an accessory oligonucleotide (ACO) enables durable and potent activity in CNS tissues. Local delivery via intracerebroventricular (ICV) or intrathecal (IT) injection into SOD1G93A mice delayed disease progression and extended animal survival with superior efficacy compared to an ASO compound resembling Tofersen in sequence and chemistry. Treatment also prevented disease-related declines in motor function including improvements in animal mobility, muscle strength, and coordination. The ACO itself does not target any specific complementary nucleic acid sequence; rather, it imparts benefits conducive to bioavailability and delivery through its chemistry. The complete conjugate (i.e., siRNA-ACO) represents a novel modality for delivery of RNAi to the CNS in which we aim to pursue ALS as an exemplary indication for clinical development.

cell biology↗

An exploration of metabolic and transcriptional responses in mouse skeletal muscles responding to acute sedentary hypoxia

Skeletal muscles are involved in responses to acute hypoxia as the largest organ in the body. However, as a hypoxic-tolerant tissue, responses in skeletal muscles caused by acute sedentary hypoxia are much less studied. We measured metabolites in skeletal muscles from mice exposed to 8% O2 for 0 minute, 15 minutes and 2 hours and studied the potential relationship between metabolite levels and mRNA levels by reconstructing genome-based metabolic networks and meta-analyzing differentially expressed genes acquired in skeletal muscles after 2 hours of 8% O2 exposure. The metabolite measurement indicated a significant increase in glutamine metabolism but not lactate metabolism in mouse skeletal muscles after 2 hours of hypoxia, where the metabolic responses as a whole were moderate. The central-dogma based metabolic flux analysis suggested an involvement of glutamine metabolism, though, as a whole, metabolite changes and gene changes didnt show a high correlation. Among metaoblites, glutamine metabolism indicated a significant response and a consistent change which could be interpreted by genome-based network analysis. In summary, though this study suggested a moderate metabolic response which has a weak correlation with gene expression change as a whole, glutamine metabolism indicated rapid responses in skeletal muscles responding to acute sedentary hypoxia.

systems biology↗

Separate neural dynamics underlying the acquisition of different auditory category structures

Current models of auditory category learning argue for a rigid specialization of hierarchically organized regions that are fine-tuned to extracting and mapping acoustic dimensions to categories. We test a competing hypothesis: the neural dynamics of emerging auditory representations are driven by category structures and learning strategies. We designed a category learning experiment where two groups of learners learned novel auditory categories with identical dimensions but differing category structures: rule-based (RB) and information-integration (II) based categories. Despite similar learning accuracies, strategies and cortico-striatal systems processing feedback differed across structures. Emergent neural representations of category information within an auditory frontotemporal pathway exclusively for the II learning task. In contrast, the RB task yielded neural representations within distributed regions involved in cognitive control that emerged at different time-points of learning. Our results demonstrate that learners neural systems are flexible and show distinct spatiotemporal patterns that are not dimension-specific but reflect underlying category structures. SignificanceWhether it is an alarm signifying danger or the characteristics of background noise, humans are capable of rapid auditory learning. Extant models posit that novel auditory representations emerge in the superior temporal gyrus, a region specialized for extracting behaviorally relevant auditory dimensions and transformed onto decisions via the dorsal auditory stream. Using a computational cognitive neuroscience approach, we offer an alternative viewpoint: emergent auditory representations are highly flexible, showing distinct spatial and temporal trajectories that reflect different category structures.

bioinformatics↗

Curvature of the retroviral capsid assembly is modulated by a molecular switch

During the maturation step, the capsid proteins (CAs) of a retrovirus assemble into polymorphic capsids, whose acute curvature is largely determined by insertion of 12 pentamers into the hexameric lattice. Despite years of intensive research, it remains elusive how the CA switches its conformation between the quasi-equivalent pentameric and hexameric assemblies to generate the acute curvature in the capsid. Here we report the high-resolution structural model of the RSV CA T=1 capsid. By comparing with our prior model of the RSV CA tubular assembly consisting entirely of hexameric lattices, we identify that a dozen of residues are the key to dictate the incorporation of acute curvatures in the capsid assembly. They undergo large torsion angle changes, which result a 34{degrees} rotation of the C-terminal domain relative to its N-terminal domain around the flexible interdomain linker, without substantial changes of either the conformation of individual domains or the assembly contact interfaces. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=82 SRC="FIGDIR/small/424437v1_ufig1.gif" ALT="Figure 1"> View larger version (33K): org.highwire.dtl.DTLVardef@40cf38org.highwire.dtl.DTLVardef@e490beorg.highwire.dtl.DTLVardef@1dae0c5org.highwire.dtl.DTLVardef@dac850_HPS_FORMAT_FIGEXP M_FIG C_FIG

biophysics↗

An Antioxidant Enzyme Therapeutic for COVID-19

The COVID-19 pandemic has taken a significant toll on people worldwide, and there are currently no specific antivirus drugs or vaccines. We report herein a therapeutic based on catalase, an antioxidant enzyme that can effectively breakdown hydrogen peroxide and minimize the downstream reactive oxygen species, which are excessively produced resulting from the infection and inflammatory process. Catalase assists to regulate production of cytokines, protect oxidative injury, and repress replication of SARS-CoV-2, as demonstrated in human leukocytes and alveolar epithelial cells, and rhesus macaques, without noticeable toxicity. Such a therapeutic can be readily manufactured at low cost as a potential treatment for COVID-19.

biochemistry↗

Functional pathways for metabolic network-based data analysis: the MetPath algorithm

Analyzing biological data using pathways helps identify trends in data tied to the function of a network. A large number of pathway-based analysis tools have been developed toward this goal. These pathways are often manually curated and thus associations are subject to the biases of the curator. A potentially attractive alternative is to define pathways based on the inherent functionality and connectivity of the network itself. Within metabolism, functionality is defined by the production and consumption of metabolites, and connectivity by metabolites participating in reactions through common enzymes. In this work, we present an algorithm, termed MetPath, that calculates pathways for production and consumption of metabolites. We show how these pathways have attractive properties, such as the ability to integrate multiple data types and weight contribution of genes within the pathway by their functional contribution to metabolite production/consumption. Pathways calculated in this manner are condition-specific and thus are custom tailored to the system of interest, in contrast to curated pathways. We find that these pathways predict gene expression correlation better compared to manually-curated pathways. Additionally, we find that these pathways can be used to understand gene expression changes between growth conditions and between cell types. This work serves to better understand the functional pathway structure underlying cell metabolism and helps to enable systems analyses of high-throughput data.

systems biology↗